Medical Student Acceptance and Perceptions of Augmented Reality Simulation
Medical Student Acceptance and Perceptions of Augmented Reality Simulation: A Mixed-Methods, Prospective Study
This prospective, single-arm, mixed-methods pilot study will evaluate medical students' experiences with, perceptions of, and acceptance of augmented reality (AR) simulation. Medical students completing their core critical care medicine (CCM) clerkship at Stanford University will take part in a single 70-minute augmented reality (AR) simulation session at the Center for Immersive and Simulation-based Learning (CISL).
The session includes one instructor-facilitated pediatric intensive care unit (PICU) scenario using an AR headset. The primary outcome is students' experiences and perceptions, explored through thematic analysis of post-simulation focus groups. Secondary outcomes are technology acceptance (Technology Acceptance Model), usability (System Usability Scale), and ergonomics (ISO 9241-400-based questionnaire).
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: Thomas Caruso, MD, PhD
- Telefonnummer: (650) 723-5728
- E-Mail: tjcaruso@stanford.edu
Studieren Sie die Kontaktsicherung
- Name: ManYee Suen, MMedSc
- Telefonnummer: (650) 723-5728
- E-Mail: smy822@stanford.edu
Studienorte
-
-
California
-
Palo Alto, California, Vereinigte Staaten, 94305
- Stanford University
-
Kontakt:
- Thomas Caruso, MD, PhD
- Telefonnummer: (650) 723-5728
- E-Mail: tjcaruso@stanford.edu
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Between age 18-50
- medical student participate in core critical care medicine (CCM) clerkship
Exclusion Criteria:
- a history of severe motion sickness
- a history of seizures cause by flashing light
- Major surgery within the last 48 hours
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Augmented Reality (AR) Simulation
Medical students on their required core critical care medicine (CCM) clerkship take part in one instructor-facilitated pediatric critical care (PICU) simulation using an augmented reality headset. The scenario covers recognizing and managing a clinically deteriorating patient. After the session, participants complete the Technology Acceptance Model (TAM) questionnaire, the System Usability Scale (SUS) and an ergonomics questionnaire based on ISO 9241-400. They also join a semi-structured focus group about their experience, learning, teamwork, communication and tolerance of the AR technology. |
A single facilitated simulation session using an augmented reality headset [Quest 3]. It overlays a virtual pediatric patient and clinical findings onto the physical environment. Students work in small teams to assess the patient, recognize deterioration, prioritize actions, call for help, start management and reassess, using closed-loop communication. The session lasts about 4hours and is followed by a structured debrief. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
explore medical students' experiences with and perceptions of augmented reality (AR) simulation
Zeitfenster: Immediately after intervention
|
Experiences and perceptions will be assessed through in-person, semi-structured focus group held at the end of the simulation session and led by a trained facilitator using a focus group guide. The guide contains six core questions plus probing prompts assessing attitudes, opinions, and perceptions of the intervention experience. Each focus group will last about 30 minutes and will be audio-recorded, transcribed, and de-identified. |
Immediately after intervention
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Technology acceptance
Zeitfenster: immediately after the intervention
|
Technology acceptance will be assessed using an adapted Technology Acceptance Model (TAM) questionnaire immediately after the Augmented Reality simulation session. TAM contains 34 items rating on a 5-point Likert scale from 1 = strongly disagree to 5 = strongly agree. The items cover eight constructs: perceived usefulness (5 items), perceived ease of use (5 items), perceived enjoyment (4 items), intention to use (4 items), curiosity (4 items), social influence (4 items), facilitating conditions (4 items), and habit (4 items). where higher scores mean stronger agreement with that construct. |
immediately after the intervention
|
|
System Usability
Zeitfenster: immediately after the intervention
|
Usability will be assessed using the System Usability Scale immediately after the Augmented Reality simulation session, rating each of the 10 items on a 5-point Likert scale from 1 = strongly disagree to 5 = strongly agree. Scores will be calculated using the standard SUS method: for odd-numbered items, 1 will be subtracted from the response; for even-numbered items, the response will be subtracted from 5. The adjusted item scores will be summed and multiplied by 2.5 to produce a total score from 0 to 100. |
immediately after the intervention
|
|
Ergonomics
Zeitfenster: immediately after the intervention
|
Ergonomics will be assessed post-intervention using the ISO 9241-400. ISO 9241-400 contains 6-item with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree. |
immediately after the intervention
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 89744
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .